Old Web
English
Sign In
Acemap
>
Paper
>
P45.05 Sequencing of PD-1 Inhibitors and TKIs in Metastatic NSCLC with MET Exon 14 Skipping Mutation May Influence Survival
P45.05 Sequencing of PD-1 Inhibitors and TKIs in Metastatic NSCLC with MET Exon 14 Skipping Mutation May Influence Survival
2021
S. Lau
Kirstin Perdrizet
D. Giffoni M. M. Mata
Andrea S Fung
G. Liu
P.A. Bradbury
Frances A. Shepherd
Adrian G. Sacher
Brandon S. Sheffield
David M. Hwang
M. Tsao
Susanna Y. Cheng
Parneet Cheema
Natasha B. Leighl
Keywords:
Cancer research
Medicine
MET Exon 14 Skipping Mutation
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]